<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940627-0-00246</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Vaginal cytology evaluation <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  means the use of wet vaginal cell  <!-- PJG 0012 frnewline --> smears to determine the phase of a test animal's estrous cycle  <!-- PJG 0012 frnewline --> and the potential for adverse exposure effects on the regularity  <!-- PJG 0012 frnewline --> of the animal's cycle. In the rat, common cell types found in  <!-- PJG 0012 frnewline --> the smears correlate well with the various stages of the estrous  <!-- PJG 0012 frnewline --> cycle and to changes occurring in the reproductive tract.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (c)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Principle of the test method. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (1) For a two week period before exposures start, daily vaginal cell smears are examined from a surplus of female test animals to identify and cull those females which are acyclic.  <!-- PJG 0012 frnewline --> After culling, testers shall randomly assign at each exposure  <!-- PJG 0012 frnewline --> concentration (including unexposed) a minimum of twenty-five  <!-- PJG 0012 frnewline --> females for breeding and fifteen non-bred females for later  <!-- PJG 0012 frnewline --> histologic evaluation. Test animals shall be exposed by  <!-- PJG 0012 frnewline --> inhalation to graduated concentrations of the test atmosphere for  <!-- PJG 0012 frnewline --> a minimum of six hours per day over the next 13 weeks. Males and  <!-- PJG 0012 frnewline --> females in both test and control groups are mated after nine  <!-- PJG 0012 frnewline --> weeks of exposure. Exposures for pregnant females continue  <!-- PJG 0012 frnewline --> through gestation day 15, while exposures for males and all non-  <!-- PJG 0012 frnewline --> pregnant females shall continue for the full exposure period.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (2) Beginning two weeks before the start of the mating  <!-- PJG 0012 frnewline --> period, daily vaginal smears resume for all to-be-bred females to  <!-- PJG 0012 frnewline --> characterize their estrous cycles. This will continue for four  <!-- PJG 0012 frnewline --> weeks or until a rat's pregnancy is confirmed,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> i.e. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , day 0, by  <!-- PJG 0012 frnewline --> the presence of sperm in the cell smear. On pregnancy day 20,  <!-- PJG 0012 frnewline --> shortly before the expected date of delivery, each pregnant  <!-- PJG 0012 frnewline --> female is sacrificed, her uterus removed, and the contents  <!-- PJG 0012 frnewline --> examined for embryonic or fetal deaths, and live fetuses. At the  <!-- PJG 0012 frnewline --> end of the exposure period, males and all non-pregnant females  <!-- PJG 0012 frnewline --> shall be weighed, and various organs and tissues, as appropriate,  <!-- PJG 0012 frnewline --> shall be removed and weighed, fixed with stain, and sectioned for  <!-- PJG 0012 frnewline --> viewing under a light microscope.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (3) This assay may be done separately or in combination  <!-- PJG 0012 frnewline --> with the subchronic toxicity study, pursuant to the provisions in  <!-- PJG 0012 frnewline --> &sect;79.62.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (d)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Limit test. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  If a test at one dose level of the highest  <!-- PJG 0012 frnewline --> concentration that can be achieved while maintaining a particle  <!-- PJG 0012 frnewline --> size distribution with a mass median aerodynamic diameter (MMAD)  <!-- PJG 0012 frnewline --> of 4 micrometers (&mu;m) or less, using the procedures described in  <!-- PJG 0012 frnewline --> section 79.60 of this part produces no observable toxic effects  <!-- PJG 0012 frnewline --> and if toxicity would not be expected based upon data of  <!-- PJG 0012 frnewline --> structurally related compounds, then a full study using three  <!-- PJG 0012 frnewline --> dose levels might not be necessary. Expected human exposure  <!-- PJG 0012 frnewline --> though may indicate the need for a higher dose level.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (e)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Test procedures <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> _(1)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Animal selection <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> _(i)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Species and strain. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  The rat is the preferred species. Strains with low fecundity shall not be used and the candidate species shall be characterized for its sensitivity to developmental toxins. If another rodent species is used, the tester shall provide justification for its selection.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (ii) Animals shall be a minimum of 10 weeks old at the  <!-- PJG 0012 frnewline --> start of the exposure period.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (iii)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Number and sex. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Each test and control group shall  <!-- PJG 0012 frnewline --> have a minimum of 25 males and 40 females. In order to ensure  <!-- PJG 0012 frnewline --> that sufficient pups are produced to permit meaningful evaluation  <!-- PJG 0012 frnewline --> of the potential developmental toxicity of the test substance,  <!-- PJG 0012 frnewline --> twenty pregnant test animals are required for each exposure and  <!-- PJG 0012 frnewline --> control level.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (2)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Observation period. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  The observation period shall be 13  <!-- PJG 0012 frnewline --> weeks, at a minimum.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (3)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Concentration levels and concentration selection. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (i) To select the appropriate concentration levels, a pilot or trial study may be advisable. Since pregnant animals have an increased minute ventilation as compared to non-pregnant animals, it is recommended that the trial study be conducted in pregnant animals. Similarly, since presumably the minute ventilation will vary with progression of pregnancy, the animals should be exposed during the same period of gestation as in the main study. It is not always necessary, though, to carry out a trial study in pregnant animals. Comparisons between the results of a trial study in non-pregnant animals, and the main study in pregnant animals will demonstrate whether or not the test substance is more toxic in pregnant animals. In the trial study, the concentration producing embryonic or fetal lethalities or maternal toxicity should be determined.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (ii) The highest concentration level shall induce some  <!-- PJG 0012 frnewline --> overt maternal toxicity such as reduced body weight or body  <!-- PJG 0012 frnewline --> weight gain, but not more than 10 percent maternal deaths.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (iii) The lowest concentration level shall not produce any  <!-- PJG 0012 frnewline --> grossly observable evidence of either maternal or developmental  <!-- PJG 0012 frnewline --> toxicity.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (4)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Inhalation exposure. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (i) All data developed within this study shall be in accordance with good laboratory practice provisions under &sect;79.60.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (ii) The general conduct of this study shall be in  <!-- PJG 0012 frnewline --> accordance with the vehicle emissions inhalation exposure  <!-- PJG 0012 frnewline --> guideline in &sect;79.61.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (f)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Test performance <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> _(1)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Study conduct. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Directions specific to this study are:  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            